{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03681275",
            "orgStudyIdInfo": {
                "id": "IRB-47826"
            },
            "secondaryIdInfos": [
                {
                    "id": "3R01AG069858-02W1",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/3R01AG069858-02W1"
                }
            ],
            "organization": {
                "fullName": "Stanford University",
                "class": "OTHER"
            },
            "briefTitle": "Janus Kinase Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction",
            "officialTitle": "A Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction",
            "therapeuticArea": [
                "Other"
            ],
            "study": "janus-kinase-inhibition-to-prevent-ventilator-induced-diaphragm-dysfunction"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-09-03",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11-16",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-11-16",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2018-09-20",
            "studyFirstSubmitQcDate": "2018-09-20",
            "studyFirstPostDateStruct": {
                "date": "2018-09-24",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Joseph B. Shrager, MD",
                "investigatorTitle": "Professor",
                "investigatorAffiliation": "Stanford University"
            },
            "leadSponsor": {
                "name": "Stanford University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institutes of Health (NIH)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "We intend, with this study, to prove that blocking the molecular mechanisms whose blockade prevents VIDD in animals, will indeed prevent the development of VIDD in humans as well. We believe that this evidence will serve as the required basis for proceeding with large, ICU-based clinical trial(s) of a drug to prevent VIDD."
        },
        "conditionsModule": {
            "conditions": [
                "Diaphragm Injury"
            ],
            "keywords": [
                "Ventilator-induced Diaphragm Dysfunction"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "PARTICIPANT"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 56,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Tofacitinib",
                    "type": "EXPERIMENTAL",
                    "description": "Patient will receive two days treatment with tofacitinib prior to the surgery.",
                    "interventionNames": [
                        "Drug: Tofacitinib 10 MG [Xeljanz]"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Patient will receive two days treatment with placebo prior to the surgery.",
                    "interventionNames": [
                        "Drug: Placebo to match Tofacitinib"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Tofacitinib 10 MG [Xeljanz]",
                    "description": "administered twice daily for two days",
                    "armGroupLabels": [
                        "Tofacitinib"
                    ],
                    "otherNames": [
                        "XELJANZ"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo to match Tofacitinib",
                    "description": "administered twice daily for two days",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Prevention of ventilator-induced diaphragm dysfunction by JAK inhibition",
                    "description": "Change in the force deficit that develops between the first and second muscle biopsies in the drug-treated vs. placebo groups",
                    "timeFrame": "5-6 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Increase in muscle strength due to JAK inhibition",
                    "description": "Difference in force generated by muscle biopsies taken at time point 1 (pre-mechanical ventilation) from the drug-treated vs placebo groups",
                    "timeFrame": "4-5 years"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Exploratory: Determine mechanisms of changes in muscle strength and ventilator-induced diaphragm dysfunction by JAK inhibition.",
                    "description": "Compare differences in muscle between the drug-treated and placebo groups in mitochondrial function and oxidative stress (ATP levels, citrate synthase activity, succinate dehydrogenase activity, mitochondrial respiration rate, activity of mitochondial enzymatic compexes).",
                    "timeFrame": "4-6 years"
                },
                {
                    "measure": "Exploratory: Determine mechanisms of changes in muscle strength and ventilator-induced diaphragm dysfunction by JAK inhibition.",
                    "description": "Compare differences in muscle between the drug-treated and placebo groups in proteolytic pathways (quantitative PCR for atrogein, MuRF1, and FoxO gene expression, western blot analysis for protein levels of these and protein polyubiquitination, proteasomal activity, qPCR and western blots for expression of LC3).",
                    "timeFrame": "4-6 years"
                },
                {
                    "measure": "Exploratory: Determine mechanisms of changes in muscle strength and ventilator-induced diaphragm dysfunction by JAK inhibition.",
                    "description": "Compare differences in muscle between the drug-treated and placebo groups in transcriptomic gene profiling, and metabolomic profiling..",
                    "timeFrame": "4-6 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients undergoing esophagectomy\n\nExclusion Criteria:\n\n* Patients with more than mild pulmonary dysfunction\n* Patients with any neuromuscular disease that might compromise diaphragm function\n* Patients with abnormal liver or kidney function\n* Patients taking any immunosuppressant medication (including prednisone) or antifungal medications\n* History of tuberculosis\n* Weight loss of \\>5% of body weight over previous 6 months\n* Pregnancy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "overallOfficials": [
                {
                    "name": "Joseph Shrager, MD",
                    "affiliation": "Stanford University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Stanford University Medical Center",
                    "status": "RECRUITING",
                    "city": "Stanford",
                    "state": "California",
                    "zip": "94305",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Team",
                            "role": "CONTACT",
                            "phone": "650-721-6561",
                            "email": "csadeghi@stanford.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.42411,
                        "lon": -122.16608
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "34655959",
                    "type": "BACKGROUND",
                    "citation": "Shrager JB, Wang Y, Lee M, Nesbit S, Trope W, Konsker H, Fatodu E, Berry MS, Poulstides G, Norton J, Burdon T, Backhus L, Cooke R, Tang H. Rationale and design of a mechanistic clinical trial of JAK inhibition to prevent ventilator-induced diaphragm dysfunction. Respir Med. 2021 Nov-Dec;189:106620. doi: 10.1016/j.rmed.2021.106620. Epub 2021 Sep 21."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "No plan to share IPD."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000479163",
                    "term": "Tofacitinib"
                }
            ],
            "ancestors": [
                {
                    "id": "D000075242",
                    "term": "Janus Kinase Inhibitors"
                },
                {
                    "id": "D000047428",
                    "term": "Protein Kinase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M258018",
                    "name": "Tofacitinib",
                    "asFound": "Tea",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1474",
                    "name": "Janus Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M25820",
                    "name": "Protein Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}